Phase II of Clinical Studies of SOTIO Ovarian Program Has Its First Patient

November 11, 2013

Last week was into the clinical trials of Phase II of the ovarian programme successfully enrolled the first patient. The patient was accepted into the SOV02 trials by doctors from the Ostrava University Hospital. According to information from cooperating Czech medical centres, further patients should be joining within the next few days. After obtaining all regulatory approvals, SOTIO expects to start enrolling patients also in Germany and Poland in early 2014.

This website uses cookies; by continuing to use this page, you consent to their use. More information